Sentient Science, a company that develops software and sensors used to test materials and components in the aerospace, defense and energy industries, has moved its headquarters to UB’s Jacobs Executive Development Center.
A study by researchers at UB and three Chinese research institutions is the first to find that low-level exposure to the industrial chemical trimethyltin chloride may be a risk factor for kidney stones.
Empire Genomics, Life Technologies Corporation and UB are partnering to develop world-class, gene-sequencing facilities for genetics-based clinical research on the Buffalo Niagara Medical Campus.
Clinical studies conducted at the School of Medicine and Biomedical Sciences have completed the clinical development of the first immunologic test for diagnosing one of the most common chronic diseases in the U.S.
UB researchers are developing a miniaturized version of sonar technology that could be applied inside the human body to treat diseases such as diabetes and heart failure in real time.
Jonathan Bird and Uttam Singisetti don’t act like renegades—both dress neatly and are polite in conversation. But steer the discussion to computing power, and the radical in both UB researchers begins to surface.
A UB study has found that dedicated bike lanes are not necessarily the most important factors in reducing the severity of injuries in crashes between bikes and motor vehicles.
